Search clinical trials for: Cannabinoid Receptor Agonists

Total 21538 results

University of British Columbia
Vancouver General Hospital

Withdrawn

Cannabinoids in Bipolar Affective Disorder

Bipolar Affective Disorder

Canada
Motus Therapeutics, Inc.
Michael J. Fox Foundation for Parkinson's Research

Terminated

A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation (MOVE-PD)

Parkinson's Disease

United States
New York State Psychiatric Institute

Terminated

Cannabinoids for Taxane Induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy

United States
Wake Forest University Health Sciences
Astellas Pharma US, Inc.

Terminated

Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)

Coronary Artery Disease | Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Angina

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Mood Effects of Serotonin Agonists Extended (MESA-E)

Healthy

United States
University of Illinois at Chicago

Withdrawn

Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease

Inflammatory Bowel Diseases | Crohn Disease | Cannabis
Yonsei University

Active, not recruiting

Effect of Mirabegron on Bladder Compliance

Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics

Korea, Republic of
Assiut University

Unknown

Acute and Chronic Toxicity of Some Synthetic Cannabinoids in Assiut Psychiatric Hospitals

Epidemiologic Data of Some Synthetic Cannibinoids Toxicity in Patients Presenting at Assiut University Hospital, Psychiatric Hospital of Ministry of Health) | Proportion of Acute and Chronic Abusers of Synthetic Cannibinoids Among Cases of Illicit Drugs Abuser in Studied Sites

Egypt
General Hospital of Ningxia Medical University

Not yet recruiting

90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment

Adverse Effect
Woolcock Institute of Medical Research
University of Sydney

Completed

Cannabinol Use in Patients With Insomnia Disorder (CUPID)

Insomnia Disorder

Australia
General Hospital of Ningxia Medical University

Not yet recruiting

90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients

Adverse Effect
Immunoflex Therapeutics Inc.
University of British Columbia; Dicentra Inc.

Completed

Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy Participants

Immunity Disorders

Canada
General Hospital of Ningxia Medical University

Recruiting

Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension

Outcome

China
GE Healthcare
Covance

Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients (Rapiscan PIP)

Myocardial Ischemia | Coronary Artery Disease

France, Greece, Italy, United Kingdom
M.D. Anderson Cancer Center
Astellas Scientific & Medical Affairs, Inc.

Active, not recruiting

Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking

Ischemia

United States
University of Illinois at Chicago
Astellas Pharma Inc

Completed

Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements

Coronary Artery Disease

United States
AstraZeneca

Completed

ZAP, US. Zomig for Appropriate for Primary Care

Migraine
Jazz Pharmaceuticals

Completed

An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience.

Healthy Subjects

United States
Centre for Addiction and Mental Health
National Institute on Drug Abuse (NIDA)

Completed

Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence

Cannabis Dependence

Canada
University of Chicago

Completed

Individual Differences in the Response to Drugs (TDS)

Healthy
Paul Kim

Recruiting

Allograft Dysfunction in Heart Transplant

Heart Transplant Failure and Rejection

United States
Timothy M. Bateman
Saint Luke's Health System; Saint Luke's Cardiovascular Consultants

Completed

Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging

Coronary Artery Disease

United States
Washington University School of Medicine
Astellas Pharma US, Inc.

Completed

Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (PET/MR-P)

Ischemic Heart Disease

United States
Emory University

Withdrawn

Phase Analysis and Obstructive CAD on Rubidium PET

Coronary Artery Disease

United States
University of Mississippi Medical Center

Recruiting

Effect of GLP-1 Receptor Agonists on Trabecular Bone Score

Diabetes Mellitus, Type 2 | Osteoporosis, Postmenopausal

United States
General Hospital of Ningxia Medical University

Recruiting

Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension in Preeclamptic Patients

Adverse Effect

China
University of Chicago
Astellas Pharma Inc

Completed

Stress Testing and Cardiac Magnetic Resonance

Coronary Disease

United States
Medical University of South Carolina
Astellas Pharma US, Inc.

Completed

Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System

Cardiovascular Diseases | Coronary Artery Disease

United States
University of Aarhus

Unknown

The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo

Retinal Artery Occlusion

Denmark
GlaxoSmithKline

Completed

Drug Use Investigation for IMIGRAN Tablet

Migraine Disorders
University of Alabama at Birmingham
Astellas Scientific & Medical Affairs, Inc.

Completed

Heart Rate Response to Regadenoson and Sudden Cardiac Death

Sudden Cardiac Death | Left Ventricular Systolic Dysfunction

United States
Christine Lau, MD
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation

Lung Transplant

United States
Dana-Farber Cancer Institute
Johns Hopkins University; Washington University School of Medicine; National... and other collaborators

Completed

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

Sickle Cell Disease

United States
Gilead Sciences

Terminated

Stress Echocardiography Study With Regadenoson

Coronary Artery Disease | Heart Disease

United Kingdom
GlaxoSmithKline

Completed

Special Drug Use Investigation for AMERGE® Tablet (Long-term)

Migraine Disorders
Optinose US Inc.

Completed

Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy Subjects

Migraine

United States
University of Maryland, Baltimore
Astellas Pharma US, Inc.

Completed

Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing (Rega Stress)

Cardiac Function

United States
University of Chicago
Astellas Pharma Inc

Completed

Stress CT Perfusion in Patients With Chest Pain

Coronary Artery Disease

United States
University Hospital Freiburg

Withdrawn

Aripiprazole Augmentation Therapy in Treatment-resistant Depression

Therapy-resistant Depression

Germany
Otsuka Pharmaceutical Development & Commercialization...

Completed

An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia (ASPIRE)

Schizophrenia

United States, India, South Africa, Estonia, Russian Federation, Mexico, Korea, Republic of, Malaysia, Bulgaria, Hungary, Croatia, Serbia, Poland, Romania, Puerto Rico, Slovakia, Chile, Taiwan, Thailand, Australia, Spain, Argentina, Finlan... and more
Drexel University College of Medicine

Completed

Aripiprazole in Children With Autism: A Pilot Study

Autism

United States
Lawson Health Research Institute
Bristol-Myers Squibb

Completed

Aripiprazole and Resistant Postpartum Depression

Postpartum Depression

Canada
Beijing HuiLongGuan Hospital

Unknown

Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia

Schizophrenia

China
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Alzheimer Disease

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in Patients With a History of Bipolar Disorder

Bipolar Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Alzheimer Disease

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

A Switch Study of BMS-337039 in Schizophrenic Out-patients

Schizophrenia

Belgium, Spain, Italy, Austria, Germany, France, Czech Republic, United Kingdom, Greece, Hungary
University of Cincinnati
Bristol-Myers Squibb; Children's Hospital Medical Center, Cincinnati

Completed

An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder

Bipolar Disorder
Jamaica Hospital Medical Center
Bristol-Myers Squibb; Department of Psychiatry, Jamaica Hospital Medical Center and other collaborators

Completed

Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)

Obsessive Compulsive Disorder | Schizophrenia OCD

United States
New Mexico VA Healthcare System
Bristol-Myers Squibb

Completed

The Effects of Aripiprazole on Patients With Metabolic Syndrome

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Metabolic Syndrome X

United States

Search clinical trials for: Cannabinoid Receptor Agonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations